...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: possible catalyst(s)??

 "No guarantee the expert market stock will react in any way"

Thanks Jonz, i guess thats my big concern having held this for almost a decade.

Whats the plan/out for us common shareholders?

Were pretty much paralyzed/dead money unless Don gets us on a different listing/TSX/NAZ or we see a complete buyout?

Feel like we are being held hostage while he draws big money in year after year with little to no oversight.

Share
New Message
Please login to post a reply